Company Filing History:
4 out of 153 
1 out of 4 
1 out of 1 Years Active: 2015-2020
Title: Innovations of Markus Weber
Introduction
Markus Weber is a notable inventor based in Langenfeld, Germany. He has made significant contributions to the field of oligonucleotide compounds, holding a total of six patents. His work focuses on developing innovative solutions that enhance gene expression inhibition.
Latest Patents
Among his latest patents are multimeric oligonucleotide compounds. These compounds consist of two or more target-specific oligonucleotides, such as antisense oligonucleotides (ASOs), which are resistant to cleavage and linked by a cleavable linker. This innovative approach allows for the concomitant inhibition of multiple genes' expression levels while exhibiting favorable pharmacokinetic and pharmacodynamic properties. The methods of making and utilizing these compounds are also detailed in his patents.
Career Highlights
Markus Weber has worked with prominent companies in the biotechnology sector, including Translate Bio, Inc. and Rana Therapeutics, Inc. His experience in these organizations has contributed to his expertise in the development of oligonucleotide therapies.
Collaborations
Some of his notable coworkers include Eugen Uhlmann and Romesh R Subramanian. Their collaboration has likely fostered advancements in the research and development of innovative therapeutic solutions.
Conclusion
Markus Weber's contributions to the field of oligonucleotide compounds demonstrate his commitment to advancing genetic therapies. His innovative patents and collaborations highlight his role as a leading inventor in this important area of research.